Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Master Herbs was a California-based distributor specializing in traditional Chinese medicine (TCM) and herbal supplements. The company primarily marketed products such as herbal liquids and teas to practitioners and retail consumers within the holistic health sector. It became widely known in 2016 following a major FDA recall of its Licorice Coughing Liquid, which was found to contain undeclared morphine. This regulatory action was classified as a Class I recall due to the potential for life-threatening respiratory depression in consumers. Following the recall and subsequent regulatory scrutiny, the company's operations were significantly curtailed, and it officially dissolved as a business entity in 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Master Herbs.